STYLAGE SPECIAL LIPS MEPIVACAINE (1x1ml) VIVACY
zoom_out_map
chevron_left chevron_right

STYLAGE SPECIAL LIPS MEPIVACAINE (1x1ml) VIVACY

NEW local anesthetic MEPIVACAINE.

STYLAGE BISOFT Special Lips Mépivaîne for lip augmentation to enhance the contour and definition.
The first monophasic cross-linked hyaluronic acid based gel formulated with the addition of both antioxidant agent (mannitol) and local anesthetic.

Cross-linked Hyaluronic Acid IPN-Like 18,5 mg/g + Mannitol + Mépivaîne 0,3%.

Quantity Discount You Save
10 €5.00 Up to €50.00
€82.50 (tax incl.) €82.50 (tax excl.)
Tax excluded

Description

STYLAGE SPECIAL LIPS MEPIVACAINE (1x1ml) VIVACY

NEW.

Medical device only for professional use.

STYLAGE SPECIAL LIPS MEPIVACAINE, Medical Device – Class III – CE Marking No. 0499. 

Injection is a medical procedure that requires experience and knowledge. 

Laboratoires VIVACY's goal was to develop specific products using a different local anesthetic to induce less vasodilation than Lidocain, without losing the anesthetic efficacy and safety.

Decrease in pain related to the injection
Wrinkle filling
Facial volume restoration (XXL)
Restore lip volume + improve lip contour (Special Lips)

A patented formula with Cross-Linked Hyaluronic Acid, VIVACY's proprietary IPN-Like Technology, Mannitol (Antioxidant) and Mepivacaine (Anesthetic).

STYLAGE BISOFT Special Lips Mépivaîne is the first monophasic cross-linked hyaluronic acid based gel formulated with the addition of both antioxidant agent (mannitol) and local anesthetic (0,3% Mépivaîne)  to create natural volume for smoother lips.
LIP CORRECTION AND ENHANCEMENT.

Designed and formulated to meet these requirements. Formulated from an animal free and biocompatible hyaluronan serum that magically lifts wrinkles around the mouth.

Its innovative composition results in the most effective treatment of this sensitive area. The lip is a very difficult area to treat correctly due to its mobility, vascularization and sensitivity to thermal and mechanical shocks. A product responsive to these constraints is required. 

RESULTS

Flexible and very easy to model for easy placement and a sensual and harmonious result.

INDICATION

Stylage® Lips is an injectable into and around the labial mucosa according to conventional techniques (retrograde tracing, micro-bolus) with a needle or cannula: lip volume augmentation, lip contour definition and correction, correction of a disproportionate upper or lower lip size, cupid’s Bow, reducing perioral lines or smoker's lines above the upper lip, restoring lip hydration (treatment for red dry lips).

COMPOSITION

Cross-linked Hyaluronic Acid IPN-Like 18,5 mg/g + Mannitol + Mépivaîne 0,3%.

Mannitol q.s. 1g

The antioxidant (Mannitol) plays an important role to eliminate the distressing effects of free radicals on the skin dermis, whilst stopping any gel degradation from occurring and the risk of post-injection inflammation.

Phosphate buffer pH: 7,2

1 x 1 ml prefilled syringe

Needles: 2 x 30G 1/2

The duration of the effect of a Stylage® Lips treatment is 6 - 9 months.

INJECTION

Into or around labial mucosa.

STYLAGE® Special Lips has been specifically designed to enhance the lips, creating subtle fullness and replacing the lost lip structure found with aging. Lip augmentation to enhance the contour and definition. Removal of wrinkles around the mouth.

Injected into the superficial to mid dermis for lip volume augmentation, lip contour definition and correction, correction of a disproportionate upper or lower lip size, reducing perioral lines or smoker’s lines above the upper lip and restoring lip hydration (treatment for red dry lips).

SPECIAL LIPS Hyaluronic Acid
IPN-Like
Mannitol
18,5 mg/g 1 x 1 ml 30 G1/2 Into or around labial mucosa ≈ 6-9 months
LIPS LIDOCAIN  Hyaluronic Acid IPN-Like
Mannitol
0.3% of Lidocaine
18,5 mg/g 1 x 1 ml 30 G1/2 Into or around labial mucosa ≈ 6-9 months

GAMME STYLAGE

FILLING AND SMOOTHING WRINKLES

NEW BOX BISOFT 

In 2019, VIVACY introduces Bi-SOFT, a next-generation patented injection delivery system that reinvents the concept of a traditional syringe.
The new device has a unique design and provides greater precision, comfort and control to the physician during injection of VIVACY’s dermal fillers.
SYRINGES
The new Bi-SOFT® syringes are ergonomically designed to be easy to use by young, as well as highly experienced users.  
The concave-shaped surface of the finger flange with the lifted edges helps avoid a lateral sliding of the doctor’s fingers from the gripping surface, and thereby secure the injection gesture.
GAMME STYLAGE
A UNIQUE FILLER FOR EACH TREATMENT AREA. FILLING AND SMOOTHING WRINKLES.
STYLAGE® S, M AND L
Correction of fine lines and superficial wrinkles (crow’s feet, glabellar frown lines, perioral lines), tear trough area treatment under the eye.
Filling of medium to deep naso-labial folds, smoothing of wrinkled and sagging areas, marionette lines, cheek wrinkles, hollow temple area, nasal hump reduction or nasal tip lift, earlobe reshaping.
Hand rejuvenation including volume loss treatment on the back of the hands.

The STYLAGE® Classic line is specifically designed to improve the appearance of superficial lines (STYLAGE® S) and moderate to severe wrinkles (STYLAGE® M and L).
After a careful personalized facial analysis, the physician will be able to determine the best possible STYLAGE® treatment plan for you based on your needs, skin condition, age, lifestyle and depth of the wrinkle.

-STYLAGE® Lidocaïne "Special Comfort" Range: S, M, Special Lips, L and XL.
STYLAGE® COMPOSITION CONCENTR. VOLUME NEEDLES DEPTH OF
INJECTION
DURATION
STYLAGE S LIDO Hyaluronic Acid IPN-Like
Mannitol
0.3% of Lidocaine
16 mg/g 2 x 0,8 ml 30 G1/2 Superficial to mid-dermis ≈ 9 months
STYLAGE LIPS LIDO Hyaluronic Acid IPN-Like
Mannitol
0.3% of Lidocaine
18,5 mg/g 1 x 1 ml 30 G1/2 Into or around labial mucosa ≈ 6-9 months
STYLAGE M LIDO Hyaluronic Acid IPN-Like
Mannitol
0.3% of Lidocaine
20 mg/g 2 x 1 ml 30 G1/2 Mid to deep dermis ≈ 12 months
STYLAGE L LIDO Hyaluronic Acid IPN-Like
Mannitol
0.3% of Lidocaine
24 mg/g 2 x 1 ml 27 G1/2 Deep dermis ≈ 12 months
STYLAGE XL LIDO Hyaluronic Acid IPN-Like
Mannitol
0.3% of Lidocaine
26 mg/g 2 x 1 ml 27 G1/2
23 G1/4
Deep dermis or Subcutaneous ≈ 12 months
and more
STYLAGE® Lidocaine is the only range of cross-linked hyaluronic acid dermal fillers which incorporates both a local anaesthetic (lidocaine 0,3%) and an antioxidant mannitol.
This innovative formula has been developed to improve the patient’s comfort at the moment of the injection process and to facilitate the procedure for the practitioner.
-STYLAGE® Volumising Range: XL and XXL

Cheek and cheekbone enhancement for a more youthful appearance
Face oval and chin remodeling
Correction of mid-face volume loss
STYLAGE® COMPOSITION CONCENTR. VOLUME NEEDLES DEPTH OF
INJECTION
DURATION
STYLAGE XL Cross-linked Hyaluronic Acid
IPN-Like
Mannitol
26 mg/g 2 x 1 ml 27 G1/2
23 G1/4
Deep dermis 
or Subcutaneous
≈ 12 months and more*
STYLAGE XXL Cross-linked Hyaluronic Acid
IPN-Like
Mannitol
21 mg/g 1 x 2.2 ml
----------
2 x 1 ml
21 G1/2
21 G50
----------
27 G1/2
25 G40
Subcutaneous ≈ 12 months and more*
-STYLAGE® Hydration and Revitalization: Hydro and HydroMax

STYLAGE® COMPOSITION CONCENTR. VOLUME NEEDLES DEPTH OF
INJECTION
DURATION
STYLAGE HYDRO Non-cross-linked
Hyaluronic Acid
Mannitol
14 mg/g 1 x 1 ml 30 G1/8 Superficial dermis ----------
STYLAGE HYDROMAX Cross-linked
Hyaluronic Acid
IPN-Like
Sorbitol
12,5 mg/g 1 x 1 ml 30 G1/8
30 G1/2
- Superfical dermis : nappage
- Deep dermis : point by point technique
≈ 12 months
Improving skin hydration, elasticity and skin tone
Delaying appearance of the skin ageing process.
LABORATOIRE VIVACY AESTHETICS WITH STYLAGE

STYLAGE® is the first innovative monophasic Gels consisting of cross-linked hyaluronic acid (patented IPN-Like technology) and a natural antioxidant to reduce the visual effects of ageing. It can be used for filling and smoothing wrinkles, natural lip correction, volume restoration, hydratation, chin remodeling, tear trough correction, neck, décolleté and hand rejuvenation. It is also possible to combine products for targeted treatment.

Data sheet

0.08 kg
30049000

You might also like